PL1978970T3 - Środek antykoncepcyjny - Google Patents

Środek antykoncepcyjny

Info

Publication number
PL1978970T3
PL1978970T3 PL07722763T PL07722763T PL1978970T3 PL 1978970 T3 PL1978970 T3 PL 1978970T3 PL 07722763 T PL07722763 T PL 07722763T PL 07722763 T PL07722763 T PL 07722763T PL 1978970 T3 PL1978970 T3 PL 1978970T3
Authority
PL
Poland
Prior art keywords
hormone
hydroxy
17alpha
acetoxy
chlormadinone acetate
Prior art date
Application number
PL07722763T
Other languages
English (en)
Inventor
Georg Schramm
Christa Kneip
Johannes Schneider
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of PL1978970T3 publication Critical patent/PL1978970T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
PL07722763T 2006-01-24 2007-01-23 Środek antykoncepcyjny PL1978970T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006003509A DE102006003509A1 (de) 2006-01-24 2006-01-24 Kontrazeptivum
PCT/EP2007/000551 WO2007098828A1 (de) 2006-01-24 2007-01-23 Kontrazeptivum
EP07722763A EP1978970B1 (de) 2006-01-24 2007-01-23 Kontrazeptivum

Publications (1)

Publication Number Publication Date
PL1978970T3 true PL1978970T3 (pl) 2011-08-31

Family

ID=37989176

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07722763T PL1978970T3 (pl) 2006-01-24 2007-01-23 Środek antykoncepcyjny

Country Status (7)

Country Link
US (1) US20090023694A1 (pl)
EP (1) EP1978970B1 (pl)
AT (1) ATE500834T1 (pl)
DE (2) DE102006003509A1 (pl)
ES (1) ES2362242T3 (pl)
PL (1) PL1978970T3 (pl)
WO (1) WO2007098828A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006003508A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Arzneimittel umfassend eine Hormonkombination
DE102007011486A1 (de) * 2007-03-07 2008-09-11 Grünenthal GmbH Arzneimittel umfassend wenigstens ein Gestagen
CL2009001233A1 (es) * 2008-05-21 2009-08-07 Gruenenthal Gmbh Procedimiento para la obtencion del acetato de 3 alfa-hidrocicloromadinona por reduccion del acetato de cloromadinona con un hidruro,con posterior inversion de la configuracion de la posicion 3; y uno de los compuestos intermediarios considerados.
JP5930725B2 (ja) 2012-01-17 2016-06-08 キヤノン株式会社 アモルファス合金、成形用型および光学素子の成形方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1222922B (de) * 1963-04-25 1966-08-18 Merck Ag E Verfahren zur Herstellung 6-substituierter 4, 6-Pregnadienderivate
DE4339934C2 (de) * 1993-05-07 1995-05-24 Klaus Dr Med Umbreit Ovulationshemmendes Mittel zur hormonalen Kontrazeption
DE4321957C2 (de) * 1993-07-01 1995-09-28 Marika Dr Med Ehrlich Verwendung eines hormonalen Mittels zur Therapie der Akne
CN1270718C (zh) * 1998-03-11 2006-08-23 托布乔恩·贝克斯托罗姆 表别孕烷醇酮在制备治疗甾族化合物诱导的疾病的药物中的应用
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
JP2006525358A (ja) * 2003-05-02 2006-11-09 ドゥラメド ファーマシューティカルズ， インコーポレイテッド 長期周期避妊養生法を利用するホルモン治療の方法
DE102004026679A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026669A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102006003508A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Arzneimittel umfassend eine Hormonkombination

Also Published As

Publication number Publication date
ATE500834T1 (de) 2011-03-15
US20090023694A1 (en) 2009-01-22
ES2362242T3 (es) 2011-06-30
DE502007006665D1 (de) 2011-04-21
EP1978970B1 (de) 2011-03-09
EP1978970A1 (de) 2008-10-15
DE102006003509A1 (de) 2007-07-26
WO2007098828A1 (de) 2007-09-07

Similar Documents

Publication Publication Date Title
PL2131847T3 (pl) Lek zawierający przynajmniej jeden gestagen
JP2004508398A5 (pl)
KR970069031A (ko) 당 제피로부터 스테로이드의 방출이 조절되는 약제학적 정제
CA2420292A1 (en) Contraception process and administration form for the same
CA2267743A1 (en) Low dose estrogen interrupted hormone replacement therapy
CA2179728A1 (en) Composition for a contraceptive comprising an estrogen and a gestagen
JP2010508275A5 (pl)
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
NO20062945L (no) Forlenget anvendelseskombinasjon omfattende ostrogener og progestiner
AR049112A1 (es) Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual
ATE500834T1 (de) Kontrazeptivum
SI1526856T1 (sl) Farmacevtski sestavek, ki obsega estetrolne derivate za uporabo pri zdravljenju raka
JP2008515909A5 (pl)
WO2005011617A3 (en) Transmucosal dosage forms for brain-targeted steroid chemical delivery systems
AR049197A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
MX2007013137A (es) Regimen anticonceptivo con dosificacion de estrogeno ampliada.
IL184257A0 (en) Solid peroral contraceptive drug
MX2009000950A (es) Uso del antagonista del receptor de glucocorticoide para el tratamiento de padecimientos infecciosos.
AR049196A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
HRP20090256T1 (en) Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method
EP1652526A3 (en) Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder
WO2009007454A3 (en) 8-beta-substituted estratrienes as selectively active estrogens
NO20072687L (no) Farmasoytisk prevensjonspreparat
CN101237836A (zh) 用于避孕的药物控释装置的新方案
WO2003084521A3 (en) Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy